CD4 and cancer: Using TISIDB analysis, our findings revealed that CHST12 mRNA was remarkably negatively correlated with CD4 and Type2 T-helper (Th2) cells, the infiltration of which was critical for immunotherapy producing anti-cancer immunity (Figures 4B, C).